Monogram Health

01/06/2026

Next week, Monogram CEO and Co-Founder Michael Uchrin will be speaking at J.P. Morgan’s annual healthcare conference in San Francisco.

Michael is speaking on Monday, January 12, where he’ll share more with healthcare executives and investors about Monogram's leading risk-bearing, multi-specialty provider platform for patients with multiple chronic conditions.

12/31/2025

Wishing our patients, partners, and colleagues a healthy and happy 2026 filled with purpose.

12/23/2025

Wishing everyone peace and joy this holiday season!

12/02/2025

Proud to have sent our colleagues and to attend the Conference this November in National Harbor, Maryland. As we continue to listen and engage with complex, polychronic populations across the country, it is important to understand how we can better serve and deliver treatment and care to patients enrolled in Medicaid, SNP, and Medicare Advantage programs.

This year’s conference was focused on expanding access to care, and Monogram is proud to be at the forefront of this initiative as the leading in-home, multi-specialty provider for aging patients with multiple chronic conditions. Monogram’s model brings trusted clinicians directly to patients’ homes, including rural communities. Unique to healthcare, Monogram takes a comprehensive and personalized approach to a person’s health, simultaneously evaluating and treating the whole person, including social needs, and all chronic conditions that are present (i.e., diabetes, hypertension, chronic kidney disease, heart failure, depression, COPD, and other metabolic disorders). As healthcare continues to evolve toward value-based, whole-person care, Monogram looks forward to revolutionizing the delivery of care.

11/24/2025

11/12/2025

November is National Diabetes Awareness Month, dedicated to raising awareness about diabetes, its prevention, and effective management.

To date, diabetes rates are on the rise and are often not a standalone condition. The urgency to act has never been greater. This fall, alongside the Diabetes Association, American Heart Association, and Jonas, Monogram supported the " Future of Diabetes " campaign to empower patients and providers with the latest strategies in prevention, treatment, and long-term management.

Monogram’s personalized approach to multiple-specialty, in-home treatment for patients with long-term chronic conditions is unique. Monogram Health bridges the gap between treating a condition and treating the whole person by evaluating and connecting the dots with other specialties to foster improved diabetes control and fewer complications.

Read the full article here: https://www.futureofpersonalhealth.com/diabetes/combating-specialist-fatigue-with-a-holistic-approach-to-care/

11/04/2025

Last week, Nashville Business Journal announced its “2025 Power 100: Disruptors” and selected Monogram Health’s Co-Founder and CEO, Michael Uchrin, as part of this distinguished group.

To compile this year's list, the business journal’s newsroom focused on who is having the greatest influence on the city’s economy, who is driving decisions, and who is making their mark on the community at large. "The rapid growth of Monogram Health positioned Michael Uchrin as a disruptor in the healthcare space."

To see the full list of Power 100 Disruptors, click the link below: https://www.bizjournals.com/nashville/news/2025/10/31/meet-the-2025-power-100-disruptors.html

10/23/2025

Thanks to Hannah Herner and The Nashville Post for their recent Q&A with Mike Uchrin on how/why Monogram Health is providing a modern version of those “old-fashioned doctor house calls” to improve health outcomes for patients with multiple chronic conditions.

Read the full interview here: https://www.nashvillepost.com/business/health_care/q-a-michael-uchrin-monogram-health/article_cae2a9ae-a043-4805-998c-d299a2b4e638.html

10/15/2025

Monogram Health doctors Shaminder Gupta, Gorav Bohil, and Jordan Bley enjoyed their visit to the University of Pennsylvania's Leonard Davis Institute of Health Economics (LDI) with Rachel M. Werner and her team of senior fellows to learn firsthand the findings and insights garnered from the five studies that Monogram Health supported.

Monogram Health is proud to be at the forefront of clinical research focused on enhancing access to specialty providers, improving the uptake of evidence-based treatments, advancing the financing and delivery models of care for polychronic patients, and addressing racial inequities.

Penn LDI is the University’s hub of health services research with more than 500 Senior and Associate Fellows involved in interdisciplinary healthcare research, several of whom are focused on addressing barriers to evidence-based treatment.

To learn more about Penn LDI and Monogram’s partnership, read more here: www.monogramhealth.com/press/monogram-health-donates-2-5m-to-university-of-pennsylvania-for-clinical-research-partnership-aimed-at-improving-outcomes-for-people-with-chronic-kidney-disease/

10/08/2025

Monogram Health announces new leaders to its executive ranks. As we continue to broaden our multi-specialty offerings, expand existing partnerships, and pursue new growth opportunities, we want to extend a warm thank you and welcome to Keith Swan (Chief Financial Officer) and Gus Puryear (Chief Legal Officer) for joining our mission to revolutionize the way care is delivered to polychronic patients across America.

To learn more, visit: https://www.monogramhealth.com/press/